top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Head and Neck Cancer Immunology and Immunotherapy
Advances in Head and Neck Cancer Immunology and Immunotherapy
Autore Abu-Eid Rasha
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 electronic resource (64 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato head and neck cancer
cancer immunology
Immunotharapy
Immune check point inhibitor
cancer vaccine
Regulatory T (Treg) cell
human leukocyte antigen
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557529703321
Abu-Eid Rasha  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (594 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato thymidylate synthase
cytotoxicity
1,2,3-triazole
1,3,4-oxadiazole
5-fluoruracil
pemetrexed
docking
3,4'-bis-guanidino
3-amino-4'-guanidino
diphenyl ether
phenyl pyridyl ether
intramolecular hydrogen bond
cancer cell viability
HL-60
BRAF
apoptosis
thieno[2,3-d][1,2,3]triazine
acetamide
H1299
HER2
EGFR
Bcl-2 inhibitors
Indole-based analogues
benzimidazole
MTT cytotoxic assay
cell cycle analysis
DNA fragmentation
ELISA
solid/lipid nanoparticles
phenstatin
letrozole
tubulin polymerisation inhibitor
aromatase inhibitor
breast cancer
hybrid molecule
dual-targeting molecule
designed multiple ligand
NaMSA
cyclophosphamide
histopathology
testis
urinary bladder
anticancer agents
enantioselective synthesis
gastric adenocarcinoma
tryptophanol
concentration-guided dosing
model informed dosing
physiologically based pharmacokinetics
sorafenib
tyrosil-DNA-phosphodiesterase 1
adamantane
resin acid
TDP1
cytotoxic agents
apoptosis induction
HT-29 cells
MDA-MB-231 cells
mechanism prediction
STAT inhibitors
miR-21
hydrazide derivatives
nitrogen scaffolds
mitoxantrone
cardiotoxicity
inflammation
oxidative stress
age
cumulative dose
Trk
NTRK
tissue-agnostic
larotrectinib
entrectinib
Trk fusion
protein kinase inhibitors
USFDA
cancer
patent review
generic product
doxazosin
MD simulations
combretastatin A-4
cytotoxic activity
hybrid compounds
indazole
mucin
MUC1
MUC16
immunotherapy
cancer vaccine
CAR (chimeric antigen receptor)
ADC (antibody-drug conjugate)
thiourea
interleukin-6
trypan blue assay
chalcones
exportin-1
covalent binding
CovDock
anticancer activity
xanthone
in vitro
in vivo
isolation
synthesis
heterocyclic compound
benzenesulfonamides
imidazoles
alkylated
colony formation
tumor spheroids
HDAC inhibitors
chalcone
dual inhibitors
carvedilol
kidney
toxicity
7-deaza-4'-thioadenosine derivatives
multi-kinase inhibitor
anticancer
nucleoside
Imiquimod
drug efflux
multidrug resistance
Toll-Like Receptor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarker Research and Personalized Medicine
Cancer Biomarker Research and Personalized Medicine
Autore Meehan James
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (428 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato clear cell renal cell carcinoma
radiomics
WHO/ISUP nuclear grade
multiphasic multidetector computed tomography
triple-negative breast cancer
taxane
chemotherapy
GBP5
Akt/mTOR
autophagy
IL13Rα2
renal cell carcinoma
JAK2
FOXO3
telmisartan
ovarian cancer
bioinformatics
CREB1
drug perturbation
lincRNA-p21
rectal cancer
chemoradiotherapy
colorectal cancer
long non-coding RNA
p53
predictive biomarker
intestinal anastomosis
anastomotic leak
biomarkers
precision medicine
personalized medicine
biomarker
AmpliSeq
DNA methylation
epigenetics
head and neck cancer
saliva
liquid biopsy
meta-analysis
gastric cancer
middle-up-down
haptoglobin
glycopeptide
mass spectrometry
circulating tumor cells
prostate cancer
cancer vaccine
immune response
breast cancer
predictive tools
prognostic tools
translational research
IL6ST
gp130
cytokine signalling
tissue-based biomarkers
liquid-based biomarkers
radiotherapy
radiosensitivity biomarkers
secretome
radioresistance
bladder tumor
lymphocyte-to-monocyte ratio
peripheral blood parameters
tumor recurrence
transurethral resection
lipidomics
1H-NMR
LC-MS/MS
lipoprotein subfractions
lipoprotein lipase
cancer biomarkers
hepatocellular carcinoma
p16 expression
head and neck squamous cell carcinoma
HPV genotyping
exosomes
chemoresistance
comparative oncology
One Health
microRNA
lymph node metastasis
hormone-dependent carcinogenesis
localized prostate cancer
prognostic factors
HNSCC
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674370003321
Meehan James  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui